epidiolex cannabidiol global market, epidiolex cannabidiol market industry report, epidiolex cannabidiol market research, epidiolex cannabidiol market insights, epidiolex cannabidiol market share, epidiolex cannabidiol industry.
What is the present valuation and projected CAGR of the epidiolex (cannabidiol) market?
The epidiolex (cannabidiol) market size has grown strongly in recent years. It will grow from $3.55 billion in 2024 to $3.89 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to rising focus on patient-centric medical treatments, growing research supporting cannabidiol’s efficacy in treating epilepsy, increasing patient awareness of cannabidiol’s potential therapeutic benefits, rising demand for alternative treatments to traditional anti-epileptic drugs, increase in the global demand for medical cannabis products.
The epidiolex (cannabidiol) market size is expected to see strong growth in the next few years. It will grow to $5.55 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increase in the number of insurance companies covering epidiolex, growing awareness about the side effects of traditional anti-epileptic medications, rising demand for natural, plant-based medicines, growing number of children and adults diagnosed with epilepsy, supportive government policies and frameworks for medical cannabis. Major trends in the forecast period include integration of cannabidiol into established treatment protocols, technological advancements in manufacturing processes, partnerships with healthcare organizations, integration of epidiolex into treatment plans for intractable epilepsy, use of artificial intelligence in cannabidiol product development, development of water-soluble cannabidiol for better bioavailability.
Get Your Free Sample of The Global Epidiolex (Cannabidiol) Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20777&type=smp
What key drivers have fueled the epidiolex (cannabidiol) market’s development over the years?
The increase in epilepsy cases is expected to drive the growth of the epidiolex (cannabidiol) market going forward. Epilepsy is a neurological condition marked by frequent, unprovoked seizures caused by irregular electrical activity in the brain. The increase in epilepsy cases can be attributed to factors such as better diagnosis, higher awareness, and the growing prevalence of conditions such as brain injuries, stroke, and genetic factors. Epidiolex is a prescription medication derived from cannabidiol (CBD) used to treat certain types of epilepsy. It helps reduce the frequency and severity of seizures by modulating the brain’s signaling pathways. For instance, in May 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government agency, about 2.9 million U.S. adults aged 18 and older reported having active epilepsy in 2022, which is roughly 1% of the adult population. Additionally, around 456,000 children aged 17 and younger are estimated to have active epilepsy in the US. Therefore, the increase in epilepsy cases will drive the epidiolex (cannabidiol) market.
What is the segmentation for the epidiolex (cannabidiol) market?
The epidiolex (cannabidiol) market covered in this report is segmented –
1) By Product: Oral Solution, Capsules, Oil Solution
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Application: Epilepsy Treatment, Dravet Syndrome Treatment, Lennox-Gastaut Syndrome Treatment, Seizure Management
Subsegments:
1) By Oral Solution: Standard Oral Solution, High-Concentration Oral Solution
2) By Capsules: Standard Capsules, Extended-Release Capsules
3) By Oil Solution: Standard Oil Solution, Concentrated Oil Solution
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/epidiolex-cannabidiol-global-market-report
Who are the most influential companies in the epidiolex (cannabidiol) market?
Major companies operating in the epidiolex (cannabidiol) market are Cannoid LLC, Jazz Pharmaceuticals Plc, Curaleaf Holdings Inc., Trulieve Cannabis Corp., Cresco Labs Inc., Tilray Brands Inc., Columbia Care Inc., Canopy Growth Corporation, Acreage Holdings Inc., Verano Holdings Corp., Aurora Cannabis Inc., Planet 13 Holdings Inc., The Cronos Group Inc., Folium Biosciences LLC, Green Roads of Florida LLC, Medterra CBD LLC, Endoca B.V., CV Sciences Inc., NuLeaf Naturals LLC, Isodiol International Inc., PharmaHemp d.o.o., Koi CBD LLC, Elixinol Global Limited, Vapen CBD LLC, 180 Life Sciences Corp.
What are the top industry trends projected to impact the epidiolex (cannabidiol) market?
Major companies operating in the epidiolex (cannabidiol) market are focusing on developing innovative products, such as synthetic cannabidiol (CBD) products designed to gain a competitive edge in the market. A synthetic cannabidiol (CBD) product is a lab-manufactured formulation of CBD designed to replicate the therapeutic effects of natural CBD without the presence of tetrahydrocannabinol (THC). For instance, in January 2024, Akumentis Healthcare Ltd., an India-based pharmaceutical company, launched Clasepi, a DCGI-approved synthetic cannabidiol (CBD) product designed to treat seizures associated with lennox-gastaut syndrome (LGS), dravet syndrome, and tuberous sclerosis complex (TSC) in patients aged 1 year and older. It is the first synthetic CBD of its kind to be available in India, with less than 0.1% THC, making it non-psychotropic. Clinical studies have shown that Clasepi is effective in reducing seizures, particularly in cases where traditional antiseizure medications have failed. The product comes with usage guidelines and is not recommended for individuals allergic to cannabidiol or any of its ingredients. Adhering to healthcare providers’ instructions is critical for optimal use and safety.
What are the major regional insights for the epidiolex (cannabidiol) market, and which region holds the top position?
North America was the largest region in the epidiolex (cannabidiol) market in 2024. The regions covered in the epidiolex (cannabidiol) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Epidiolex (Cannabidiol) Market Report 2025 Offer?
The epidiolex (cannabidiol) market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Epidiolex is a prescribed medication that contains cannabidiol (CBD), a compound derived from the cannabis plant. It is primarily used to treat two rare and severe forms of epilepsy—Lennox-Gastaut syndrome (LGS) and Dravet syndrome—in patients aged 1 year and older. Epidiolex works by reducing the frequency and severity of seizures through its action on the endocannabinoid system, although the exact mechanism is not fully understood.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20777
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
